| Autor: |
Lobo, Catarina S., Rodrigues-Santos, Paulo, Pereira, Dina, Núñez, Jisette, Trêpa, João C. D., Sousa, David Lopes, Lourenço, Jorge Vaz, Coelho, Maria Filomena, de Almeida, Luis Pereira, da Cunha, José Saraiva, Arnaut, Luis G. |
| Předmět: |
|
| Zdroj: |
Photochemical & Photobiological Sciences; Jun2022, Vol. 21 Issue 6, p1101-1109, 9p |
| Abstrakt: |
The amplitude of the coronavirus disease 2019 (COVID-19) pandemic motivated global efforts to find therapeutics that avert severe forms of this illness. The urgency of the medical needs privileged repositioning of approved medicines. Methylene blue (MB) has been in clinical use for a century and proved especially useful as a photosensitizer for photodynamic disinfection (PDI). We describe the use of MB to photo-inactivate SARS-CoV-2 in samples collected from COVID-19 patients. One minute of treatment can reduce the percentage inhibition of amplification by 99.99% under conditions of low cytotoxicity. We employed a pseudotyped lentiviral vector (LVs) encoding the luciferase reporter gene and exhibiting the S protein of SARS-CoV-2 at its surface, to infect human ACE2-expressing HEK293T cells. Pre-treatment of LVs with MB-PDI prevented infection at low micromolar MB concentrations and 1 min of illumination. These results reveal the potential of MB-PDI to reduce viral loads in the nasal cavity and oropharynx in the early stages of COVID-19, which may be employed to curb the transmission and severity of the disease. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Full text from SpringerLink